Armand Girard
About Armand Girard
Title: Chief Business Officer
Armand Girard holds the title of Chief Business Officer. He brings a wealth of experience to this role with over 25 years in strategic planning, corporate development, clinical development, and business development. His extensive background provides him with a comprehensive understanding of the pharmaceutical and biotech industries.
Corporate Development and Strategic Planning Expertise
Armand Girard has a rich background in corporate development and strategic planning. His experience spans over 25 years, during which he has successfully completed numerous collaborations, licenses, acquisitions, and spinouts. These endeavors were conducted with leading pharmaceutical and biotech companies, showcasing his capability in developing and executing strategic corporate initiatives.
Experience at GlycoMimetics
Before his current role, Armand Girard served as the Chief Business Officer at GlycoMimetics. During his tenure, he was responsible for corporate strategy, partnering, and managing corporate and institutional alliances. This included supporting the development of uproleselan, reflecting his capabilities in driving strategic pharmaceutical projects and partnerships.
Previous Roles at Shire Pharmaceuticals
Prior to joining GlycoMimetics, Armand Girard worked at Shire Pharmaceuticals. He held significant positions including Vice President, Technical Assessment and Senior Director for Business Development. In these roles, he was key in building the product pipeline and supporting Shire’s strategic venture arm through strategic investments. His contributions helped shape the company’s growth and innovation strategies.
Education Background
Armand Girard's academic background includes an undergraduate degree from Lehigh University. Further enhancing his expertise, he earned an MBA from St Joseph’s Haub School of Business Executive Pharmaceutical Marketing Program. This combination of technical and business education underpins his strategic and operational capabilities in the pharmaceutical industry.